NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email Judd Antin, who spent 10 years leading teams at Meta and Airbnb, says leaders should invest in middle managers, rather than cutting their jobs in the “Great Flattening.”Read More